Search - tctmd.com

Displaying 501 - 520 of 1462

Sort: Relevancy | Date

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

News Conference News AHA 2019

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Shelley Wood

November 16, 2019

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

L.A. McKeown

November 01, 2019

News Daily News

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

Yael L. Maxwell

October 28, 2019

News Conference News AHA 2019

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

Shelley Wood

October 25, 2019

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Caitlin E. Cox

October 04, 2019

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

Shelley Wood

September 29, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

News Conference News TCT 2019

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Todd Neale

September 25, 2019

News Industry News

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

September 25, 2019

Advertisement

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

ISCHEMIA: Invasive Strategy No Better Than Meds for CV Events

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality

ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Strokes Increasing in STEMI Patients With Cardiogenic Shock

CeleCor Therapeutics Announces Positive First-in-Human Data of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor, Presented at TCT 2019

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content